Since early 2019, manufacturers of pharmaceutical goods have been required to add additional security labelling to certain products sold in the European Union. Under the terms of the EU Falsified Medicines Directive (EU FMD), prescription pharmaceutical products are now required to have a verifiable 2D data matrix code and tamper-evident labelling included as part of their product packaging. In addition, Bart
Vansteenkiste at Domino Printing Sciences clarifies that a humanreadable unique serial number is required to meet the Directive’s requirements, as well as a product code, batch number, and expiry date for the contents.